Key facts
- Elektra Health’s last known valuation is $23.0M (Feb 2025).
- It has raised $13.2M; the latest was Seed Round ($4.7M) in Feb 2025.
- Notable investors include Everywhere Ventures, Flybridge (New York), Bossa Invest, City Light Capital, Company Ventures — 28 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 28 names
- ·Watchlist + deal alerts for Elektra Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Elektra Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elektra Health
Operator of a digital health company intended to provide information regarding perimenopause and menopause. The company's tool eliminates the stigma around hormones and menopause through education, community, and access to medical expertise and gives access to telemedicine care from board-certified clinicians, an evidence-based educational program, and a private community, enabling women to take ownership of their hormonal changes and live a healthy life.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 17
- Website
- elektrahealth.com/
- Ownership
- Privately Held (backing)
Elektra Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elektra Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elektra Health in its N-PORT filings yet. We sweep new filings monthly.